FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical firm with a market capitalization of $119.87 billion, announced today a 2.6% increase in its quarterly cash dividend.

Industrial real estate in desirable locations is a terrific asset. So should Stephen Wright buy shares in a FTSE 250 REIT to ...

If you need to generate income from your investments, selecting securities or funds based on their current interest or ...

For example, the recent F share price of $9.24 represents a price-to-book ratio of 0.8 and an annual dividend yield of 6.49% ...

The company's announcement that it was walking back its 2028 goals for smoke-free products warranted a closer look at its ...

Star Group continues to outperform with volume gains and solid earnings. See why SGU stock’s 12.16% return projection makes ...

This high-quality Canadian dividend stock offers an attractive yield and plenty of long-term growth potential.

The expanded accounting equation builds upon the basic accounting equation's use of assets, liabilities and equity by ...

It's also worth pointing out that CVS Health seems to have plenty of space to increase its dividend. The company's cash ...

Ares Capital reported Q4 earnings on Feb. 5, which highlighted leadership changes, solid financials, and a record net asset ...

(Reuters) - Netflix is considering a bid for Formula One's U.S. TV rights, according to a report from The Athletic on Friday.

Investor interest in cryptocurrencies -- especially Bitcoin -- has grown over time. More publicly traded companies than ever ...